Image credit: AP Photo/Kathy Young

In a First, a Cannabis-Derived Pharma Product Is Descheduled in the US

The DEA has taken Epidiolex, a CBD-based formula for rare forms of epilepsy, completely off its list of controlled substances. Why? The 2018 Farm Bill.

CBD
Congress, Newsletter

Outgoing Rep. Blumenauer Talks Banking, Hemp, and Trump

An excerpt from the Cannabis Wire Daily newsletter.

Newsletter, Regulation

Who’s Calling for a Hearing on Rescheduling?

An excerpt from the Cannabis Wire Daily newsletter.